gms | German Medical Science

104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft e. V. (DOG)

21. - 24.09.2006, Berlin

Reliability of dosing, ease of administration and daily costs in glaucoma combination therapy in Germany, Switzerland, UK and Ireland

Meeting Abstract

Suche in Medline nach

  • A. P. Buchholz - Diakonissenkrankenhaus Karlsruhe-Rüppurr, Augenabteilung, Karlsruhe, Germany
  • M. Tan - Städtisches Klinikum Karlsruhe, Augenklinik, Karlsruhe, Germany

Deutsche Ophthalmologische Gesellschaft e.V.. 104. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft (DOG). Berlin, 21.-24.09.2006. Düsseldorf, Köln: German Medical Science; 2006. Doc06dogP294

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter: http://www.egms.de/de/meetings/dog2006/06dog816.shtml

Veröffentlicht: 18. September 2006

© 2006 Buchholz et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.de). Er darf vervielf&aauml;ltigt, verbreitet und &oauml;ffentlich zug&aauml;nglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.


Gliederung

Text

Objective

To assess ease of use, dosing reliability and daily treatment costs with currently existing fixed combination therapies.

Methods

Three ophthalmologists and 1 elderly patient were asked to evaluate use of Cosopt, Xalacom and Combigan. They performed drop count and rated product handling. Daily treatment costs were then compared in 4 countries, including Germany.

Results

All bottles were sufficient for 1 month of treatment. Least variability in drop numbers was found for Combigan. Handling of the Cosopt bottle was found to be most difficult. Daily treatment costs were highest for Xalacom.

Conclusions

These findings suggest that Combigan has the highest dosing reliability overall. Combigan also has lowest daily costs in two countries. Xalacom costs were highest in all 4 countries.